Currently out of the existing stock ratings of Andrew Mok, 15 are a SELL (10.95%), 35 are a HOLD (25.55%), 87 are a BUY (63.5%).

Andrew Mok

Work Performance Price Targets & Ratings Chart

Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 42.23% that have a potential upside of 10.9% achieved within 89 days. Previously, Andrew Mok worked at UBS.

Andrew Mok’s has documented 279 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACHC, Acadia Healthcare Company at 28-Feb-2025.

Wall Street Analyst Andrew Mok

Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for AMED (AMEDISYS) at 11/1/2022. The price target of $88 was fulfilled within 2 days with a profit of $7.12 (7.49%) receiving and performance score of 37.43.

Average potential price target upside

of $54.28 (20.17%) on HCA (HCA HOLDINGS).
of $29.24 (36.89%) on THC (TENET HEALTHCARE).
of $18.79 (16.6%) on DVA (DAVITA HEALTHCARE PARTNERS).

AMED Amedisys CYH Community Health Systems THC Tenet Healthcare UHS Universal Health Services EHC Encompass Health Corp HCA HCA Holdings ACHC Acadia Healthcare Company LHCG LHC Group OSH Oak Street Health DVA DaVita HealthCare Partners CANO Cano Health CMAX CareMax EHAB Enhabit PRVA Privia Health Group ALHC Alignment Healthcare LLC CI Cigna Corp CNC Centene Corp CVS CVS Health Corp ELV Elevance Health HUM Humana MOH Molina Healthcare RDNT RadNet

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Justin Bowers (DEUTSCHE BANK)